| Code | CSB-MP6176MOV |
| Abbreviation | Recombinant Cynomolgus monkey LTBR protein, partial (Active) |
| MSDS | |
| Size | $138 |
| Order now | |
| Image |
|
| Have Questions? | Leave a Message or Start an on-line Chat |
Lymphotoxin beta receptor mediates critical signals in lymphoid organogenesis and immune homeostasis, making its extracellular domain a key target for dissecting TNFSF14/LIGHT interactions in primate models. This cynomolgus macaque LTBR fragment spanning residues 28–229 demonstrates quantifiable binding to human TNFSF14 with an EC50 of 11.83–14.23 ng/ml in functional ELISA, providing a validated reagent for ligand-binding assays, competitive inhibition studies, and blocking antibody screening in translational research. Mammalian cell expression preserves the native glycosylation and disulfide architecture essential for physiological receptor conformation, supporting its use in therapeutic antibody epitope mapping, SPR-based affinity characterization, and small-molecule inhibitor screening campaigns. The protein meets the purity and endotoxin criteria typical for quantitative binding assays, with >95% purity by SDS-PAGE and <1.0 EU/μg endotoxin, aligning with standards expected in drug discovery workflows targeting the lymphotoxin pathway.
There are currently no reviews for this product.